This course will present four challenging brain metastases cases and variations thereof that speak to the following themes: multiple brain metastases, brain metastases responsive to systemic therapy agents, complications of radiotherapy including neurocognitive effects, and large radiotherapy tar
Liver cancer incidence is growing faster than any other cancer in men and women. It is evident that the optimal care of patients with HCC necessitates the involvement of a multidisciplinary team utilizing evidence-based cancer guidelines.
This activity will discuss current clinical scenarios in prostate cancer with an expert panel discussing decision points starting from a patient case but expanding to include audience responses, the panel's opinion, and finally discussing the evidence and guidelines for each situation.
This course will discuss current evidence and emerging treatment options in the management of SCLC. An overview of small cell lung cancer (SCLC) will be provided including definitions, staging, epidemiology, pathology and ongoing clinical trials.
In this course, through complex head and neck case examples, a multidisciplinary panel will discuss the relative merits of primary chemoradiation approaches and/or surgical approaches for locally advanced head and neck cancer in the context of optimizing cure, while considering organ preservation
Biomarkers have revolutionized how we treat certain cancers (e.g. breast cancer, medulloblastoma, H&N cancer, etc.), sometimes even providing more prognostic information than traditional measures such as age, stage, grade and performance status.
At the PRO session for the AM2018, it was noted that community radiation oncologists are increasingly finding oligometastases as part of their practice or being referred these patients after advanced staging by medical oncology or urology.